Children’s montelukast sodium chewable tablets are medicated for the prevention and long-term treatment of asthma in children aged 2 to 14 years.
Children’s montelukast sodium chewable tablets are a potent oral preparation for improving inflammatory markers of asthma, mainly used for asthma prophylaxis and long-term treatment of children aged 2 to 14 years, with significant efficacy in aspirin-sensitive asthma patients. It can also be used to reduce symptoms caused by seasonal allergic rhinitis, such as nasal congestion, decreased sense of smell, sneezing and other symptoms.
Montelukast sodium chewable tablets are very effective in the treatment of asthma in children, and many mild forms of childhood asthma can be controlled by persistent oral intake of Montelukast sodium for recurrent wheezing symptoms.
A small number of people are prone to upper respiratory tract infections, blood lymphatic system disorders, immune system disorders and other adverse reactions, allergic to the product, pregnant women and other people are prohibited from using.
Specific drugs should be taken under the guidance of a doctor to use correctly, to avoid the adverse effects of private medication.